Search for Fragility Indicators Among People Aged 50+ With Chronic HIV Infection

Frail in HIV Population Clinical Trial

— Visage 3  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02874118
• Other study ID #: 2011-41
• Secondary ID: 2011-A01679-32
• Status: Completed
• Phase: N/A
• Start date: September 26, 2012
• Est. completion date: April 6, 2023

Study information

• Verified date: April 2023
• Source: Assistance Publique Hopitaux De Marseille
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The frailty and frail elderly was defined in 2001 by Fried as a physiological state of heightened vulnerability to external shocks. 5 criteria for classifying the elderly in 3 categories: frail, pre-frail and not frail. The prevalence of frailty in the general population was estimated to be 7%, 10% and 20% for over 65 years and 45% for over 85 years. This concept is explored in some chronic diseases, in order to prevent the loss of autonomy and tailor the treatment. In the carrier population of HIV, a North American retrospective study showed the frailty syndrome manifested as early as 10 years before, than in the general population. Furthermore various studies show in this specific population, increased incidence of diseases linked to age, suggesting an accelerated and premature aging.

objectives: The objective of this study is to determine the prevalence of frailty defined Fried syndrome in a population of subjects aged 50 and over Holders of chronic HIV infection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 510
• Est. completion date: April 6, 2023
• Est. primary completion date: June 10, 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• Patient with HIV and followed in the southeastern France area

Exclusion Criteria:

• In patient HIV infected patient

• HIV patient disabled (spastic)

• HIV infected for less than a year

Related Conditions & MeSH terms

• Frail in HIV Population

Intervention

Behavioral:
• Fried scale for frailty assessement

Locations

Country	Name	City	State
France	Assistance Publique Hôpitaux de Marseille	Marseille

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of frailed patient among the HIV population folloxed in southeastern France area		one year